CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Industry sector: Retail/Wholesale
Sector classification: Drug stores & proprietary stores
Deep Learning based analysis and prediction model for CVS Corporation (CVS) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 2, 2015.
Market data for CVS model training are being downloaded from the
Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for CVS.
Model is being retrained on a daily basis.
|% Held by Insiders||0.53%|
|% Held by Institutions||84.03%|
|EPS (last reported FY)||$5.90|
|EPS (last reported Q)||$1.48|
|EPS, estimated (last reported Q)||$1.39|
|Total revenues||$185 B|
|Net income||$7 B|